Home > Boards > US Listed > Biotechs > PharmaCyte Biotech Inc. (PMCB)

LAGUNA HILLS, Calif. --(BUSINESS WIRE)-- PharmaCyte Biotech,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
longboarder7892 Member Profile
 
Followed By 20
Posts 2,180
Boards Moderated 4
Alias Born 12/06/17
160x600 placeholder
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation Business Wire - 11/12/2021 9:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/8/2021 6:01:27 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 11/4/2021 7:39:35 AM
PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA Business Wire - 9/27/2021 9:00:00 AM
PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests Business Wire - 9/21/2021 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/14/2021 8:02:08 AM
PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/8/2021 9:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/3/2021 7:20:53 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/1/2021 6:04:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:25:24 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:23 PM
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study Business Wire - 8/31/2021 9:20:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/30/2021 8:31:26 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/30/2021 6:31:47 AM
PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise Business Wire - 8/25/2021 9:00:00 AM
PharmaCyte Biotech Announces Closing of $70 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Business Wire - 8/23/2021 4:39:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/23/2021 6:09:01 AM
Big movements in Pharmacyt Biotch stock price on Thursday moving 28.36% between high and low StockInvest.us - 8/19/2021 8:10:18 PM
longboarder7892   Wednesday, 09/08/21 09:02:52 AM
Re: None
Post # of 144070 
LAGUNA HILLS, Calif. --(BUSINESS WIRE)-- PharmaCyte Biotech, Inc. (NASDAQ: PMCB) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually September 13-15, 2021 .
PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner , who will deliver a presentation about PharmaCyte and participate in virtual meetings with institutional investors throughout the conference, said, “We are extremely honored to present at H.C. Wainwright’s 23rd Annual Global Investment Conference . PharmaCyte is forever grateful to H.C. Wainwright for bringing institutional investors to our door so that we could present our story in two separate capital raises that generated about $90 million .”
Mr. Waggoner continued, “For the first time in PharmaCyte’s history, we have the opportunity to develop treatments for cancer, diabetes, and malignant ascites fluid without being constrained by finances or the need to raise additional capital. We owe that to H.C. Wainwright and its institutional clients. Presenting at the firm’s Global Investment Conference gives PharmaCyte a platform to continue to tell our story and drive attention to the work we’re doing in developing treatments for hard-to-treat diseases.”
Mr. Waggoner’s presentation will provide an overview of the Company’s business. It will be available on-demand through the H.C. Wainwright portal beginning on Monday, September 13, 2021 , at 7:00 a.m. EDT .


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences